COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

SARS-CoV-2 is the agent responsible for COVID-19. The infection can be dived into three phases: mild infection, the pulmonary phase and the inflammatory phase. Treatment options for the pulmonary phase include: Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir. The inflammatory phase includes ther...

Descripción completa

Detalles Bibliográficos
Autor principal: Magro, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305708/
https://www.ncbi.nlm.nih.gov/pubmed/32569708
http://dx.doi.org/10.1016/j.virusres.2020.198070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305708/
https://www.ncbi.nlm.nih.gov/pubmed/32569708
http://dx.doi.org/10.1016/j.virusres.2020.198070

Ejemplares similares